Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Cencora, Inc.

Bloom Energy ($BE) stock jumped about 6% in Friday’s extended trading session after the S&P Dow Jones Indices announced its addition to the S&P 500...

Bloom Energy Stock (BE) Is Rising 6% in Friday’s After-Hours Trading – Here’s Why

Curzon Energy PLC ( ($GB:COR) ) has provided an update. Corpus Resources Plc reported that all resolutions tabled at its Annual General Meeting on ...

Corpus Resources Secures Strong Shareholder Backing at AGM

Global Cord Blood ( ($CORBF) ) has issued an announcement. Global Cord Blood Corporation, a cord blood banking provider domiciled in the Cayman Isl...

Global Cord Blood Issues Seventeenth Joint Provisional Liquidators’ Report in Ongoing Cayman Proceedings

Cordiant Digital Infrastructure Limited ( ($GB:CORD) ) just unveiled an update. Cordiant Digital Infrastructure is set to feature as a guest on Quo...

Cordiant Digital Infrastructure to join QuotedData infrastructure investment webinar

The latest update is out from Camino Minerals ( ($TSE:COR) ). Camino Minerals Corporation has closed a C$5.8 million brokered private placement of ...

Camino Minerals Raises C$15.2 Million Through Equity and Convertible Debenture Placements

Curzon Energy PLC ( ($GB:COR) ) has provided an update. Corpus Resources reported an unaudited loss of US$246,413 for the six months to 30 June 202...

Corpus Resources Swings to Loss as It Seeks Oil and Gas Deals and Fresh Funding

In a report released yesterday, Allen Lutz from Bank of America Securities maintained a Hold rating on Cencora, with a price target of $330.00. The...

Bank of America Securities Remains a Hold on Cencora (COR)

Cencora ( ($COR) ) just unveiled an announcement. Beginning July 1, 2026, certain Walgreens volume that had been serviced by Cencora outside its pr...

Cencora Reaffirms 2026 EPS Outlook Amid Walgreens Shift

Global Cord Blood ( ($CORBF) ) has provided an announcement. Global Cord Blood Corporation, which has been under provisional liquidation since a Se...

Global Cord Blood Liquidators Seek Court Approval for Third Fee Report Amid Shareholder Register Dispute

In a report released today, Stephen Baxter from Wells Fargo assigned a Buy rating to Cencora, with a price target of $395.00. According to TipRanks...

Wells Fargo Gives a Buy Rating to Cencora (COR)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cencora (COR), Takeda Pharmaceutical Company (TAK) and Schrodinge...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	COR	$330.95	-1.86%	1.03M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	COR	$330.95	-1.9%	1.03M
3
4
5
6

COR

Get Cencora, Inc. Data in Excel

Get Cencora, Inc. Data in Excel